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Eyelid Microcystic Adnexal Carcinoma
Richard J. Hesse, MD; John C. Scharfenberg, MD; John L. Ratz, MD; Eric Griener, MD
Microcystic adnexal carcinoma is an uncommon cutaneous tumor with multiple syn-onyms. On cursory microscopic examination, the tumor mimics syringoma andother benign skin adnexal tumors. However, the asymmetric, infiltrative growthpattern clearly sets the lesion apart as carcinoma. The tumor is locally aggressive,
with recurrences common, but regional metastases are rare. Histogenesis is controversial. Optimal
treatment consists of complete surgical excision with clear surgical margins.
(Arch Ophthalmol. 1995;113:494-496)
Microcystic adnexal carcinoma (MAC) is
an uncommon tumor known by a variety
of names, including combined adnexal tu¬
mor of the skin, ' sclerosing sweat duct car¬
cinoma,2'3 microcystic carcinoma,4 sweat
gland carcinoma with syringomatous fea¬
tures,5·6 and malignant syringoma.7 It is a
locally aggressive lesion with a strong ten¬
dency for local recurrence if incompletely
excised. Histologically, MAC can be con¬
fused with benign skin adnexal neoplasms.
The face is the most common site.8 Glatt
et al7 and LeBoit and Sexton9 each described
two periocular cases. We treated one pa¬
tient with an upper-eyelid-eyebrow lesion.
REPORT OF A CASE
A 35-year-old woman had a 0.2-cm non-
ulcerated cutaneous nodule with a 1-cm
circumferential zone of induration involv¬
ing her right upper eyelid and eyebrow.
She did not have excessively sun-
damaged skin for her age, and she had not
had facial radiotherapy. Punch biopsy dis¬
closed a sweat gland neoplasm, not oth¬
erwise specified.
Complete surgical excision with the
Mohs micrographie technique left a sub¬
stantial defect (Figure 1 ). The defect was
closed by a combination of Z-plasties and
rhomboid ñaps (Figure 2). The initial
cosmetic result was acceptable (Figure 3).
Eyebrow tattooing and scar dermabra-
sion followed, with good effect. There has
been no recurrence after 2 years.
PATHOLOGIC FINDINGS
The surgical excision of skin and subcu¬
taneous tissue displayed an asymmetric,
poorly circumscribed tumor that was
broader than it was deep. There was no
continuity of the lesion with the surface
epithelium. Tumor extended into the
deeper dermis, subcutaneous tissues, and
muscle (Figure 4).
The tumor was composed of small
epithelial cells. In the superficial portion
of the lesion, small keratocysts were noted(Figure 5). At middermal levels, micro-
tubules and thin trabeculae predomi¬
nated. There was focal invasion of the peri-
neural space (Figure 6). The epithelial
constituents in the dermis and subcutis
were surrounded by abundant, dense, hya-
linized stroma. Mitoses and necrosis were
not features of the tumor.
A battery of immunostains demon¬
strated that the tumor cells were positive
with antibodies to high- and low-
molecular weight keratin, and negative
with antibodies for epithelial membrane
antigen and S100 protein. The tumor cells
and intraluminal contents did not react
with antibodies to carcinoembryonic an-
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Figure 1. Initial defect after Mohs surgical
excision.
Figure 2. Appearance after closure by
Z-plasties and rhomboid flaps.
Figure 3. Final appearance 1 year
postoperatively.
Figure 4. Overview of the tumor displaying
absence of epidermal involvement. There is
deep subcutaneous extension. The
subcutaneous fat (short arrow) is partitioned
by bands of dense hyalinized tumor-containing
stroma (long arrow) (hematoxylin-eosin,
original magnification  25).
Figure 5. Small keratocysts in the upper
portion of the lesion (hematoxylin-eosin,
original magnification  400).
Figure 6. Tumor invading the perineural space(arrow) (hematoxylin-eosin, original
magnification  400).
tigen on paraffin-embedded sec¬
tions. Intact, uninvolved eccrine el¬
ements served as a striking built-in
positive control.
COMMENT
Microcystic adnexal carcinoma is a
relatively uncommon skin append¬
age tumor. Gender distribution is
equal. Age of the patients ranges
from 18 to 76 years.2 The face was
involved in 31 of 36 cases in one ma¬
jor series.8 The case reported herein
represents the fifth one reported to
occur in a periocular location.7'9
Growth is indolent, and the time
ranges from 1 to 17 years.4 Lupton
and McMarlin10 noted that two cases
in the literature occurred after ra¬
diation therapy for acne. Lober and
Larbig" reported a case of MAC in
a 48-year-old man who had re¬
ceived thymic irradiation in child¬
hood and radiation after removal of
a thyroid carcinoma at 35 years
of age.
The lesion is usually solitary
and occurs as a nodule or an indu¬
rated, deep-seated plaque. The size
ranges from 1 to 3 cm. On superfi¬
cial microscopic exanimation, the
appearance mimics that of several
benign skin appendage tumors. Be¬
nign skin appendage tumors tend to
be symmetric and deeper than they
are broad. Like most malignant skin
appendage tumors, the silhouette of
MAC is asymmetric and broader
than it is deep. The MAC infiltrates
the dermis, subcutaneous fat, and
underlying tissues. Perineural space
invasion was noted in 80% of cases
in one series.5 Cellular atypia, ab¬
normal mitoses, and necrosis are not
features of MAC. The epithelial el¬
ements are set in abundant hyalin-
ized sclerotic stroma.
In one series,9 nine of 17 le¬
sions were initially misdiagnosed be¬
cause of the small size of the biopsy
specimen. In general, the most com¬
mon misdiagnosis is syringoma.
Clinically, syringomas are usually
small and multiple. Microscopi¬
cally, they are symmetric and do not
display perineural invasion.
The histogenesis of MAC is dis¬
puted. To some investigators, the
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presence of small keratocysts in the
upper portion of the lesion implies
pilar differentiation, and the pres¬
ence of microtubules at deeper lev¬
els implies eccrine differentiation.
These investigators postulate ori¬
gin from pluripotential adnexal ke-
ratinocytes, capable of differentiat¬
ing toward pilar and eccrine duct
structures to a variable degree within
a given tumor. Most of these inves¬
tigators designate the tumor as
MAC.1'9'11"14
Alternatively, there are those
who consider that the small kerato¬
cysts, microtubules, and solid
strands of tumor are all within the
spectrum of eccrine neoplasms. For
this group, the keratocysts are lik¬
ened to the acrosyringium of the
normal eccrine apparatus. These in¬
vestigators prefer to designate the tu¬
mor as sclerosing sweat duct carci¬
noma.3"5,8 Lipper and Peiper6
reported that by electron micros¬
copy, the tumor corresponds to be¬
nign syringoma and normal ec¬
crine ducts.
Inmunohistochemistry has not
been definitive in settling the ques¬
tion of histogenesis. Some have used
carcinoembryonic antigen expres¬
sion by tumor cells as evidence of ec¬
crine histogenesis.31516 Others con¬
sider the absence of carcino¬
embryonic antigen expression in the
areas of keratin microcysts as evi¬
dence of pilar differentiation.12 In the
case under discussion, all elements
of the tumor failed to express car¬
cinoembryonic antigen. The data
from an immunohistochemical study
ofMAC by Wick and colleagues17 are
consistent with sudoriferous and
partial pilar differentiation. Be¬
cause we support the pluripoten-
tial adnexal keratinocytic concept,
we have designated our tumor as
MAC.
In the largest series,8 one or
more local recurrences occurred in
47% of cases within 2 to 29 years af¬
ter initial therapy. Lupton and
McMarlin10 reported a recurrence
after a 30-year interval, emphasiz¬
ing the indolent biologic behavior of
MAC.
Treatment requires complete
surgical excision. Tumor-free mar¬
gins in the original specimen por¬
tend a favorable prognosis.5 One re¬
ported tumor involved an underlying
lymph node, probably by direct ex¬
tension.5 The risk for regional lymph
node metastasis is apparently low.
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